Form 4 for GH Guardant Health, Inc.
Accepted 2025-10-20 00:00:00 ET · period of report 2025-10-17 · accession 0001865525-25-000009 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-10-20 | 2025-10-17 | GH | Hidalgo Medina Manuel | Dir | M - OptEx | $0.00 | +232 | 1,315 | +21% | $0 |
| D | 2025-10-20 | 2025-10-17 | GH | Hidalgo Medina Manuel | Dir | M - OptEx | $0.00 | -232 | 7,657 | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-17 | M | A | 232 | $0.00 | 1,315 | D | — | — | |
| 2 | Derivative | Restricted Stock Units | 2025-10-17 | M | D | 232 | $0.00 | 7,657 | D | $0.00 · — to — | 232 Common Stock | (F1) The restricted stock unit granted on July 17, 2024 vests over a four-year period. 25% of the shares subject to such award vested on the one-year anniversary of July 17, 2024. The remaining 75% vests monthly for the three-year period thereafter. (F2) Not applicable for Restricted Stock Units. |